Biorchestra

Biorchestra is a biotech company in Cambridge, United States, founded in 2016.

RNA therapeutics for a paradigm shift in neurodegenerative disease

Employees
51–200
Founded
2016
Business Model
B2B

About

BIORCHESTRA is an innovative biotech company focused on the research and development of ribonucleic acid (RNA) based therapeutics for neurodegenerative diseases. The company's mission is to shift the therapeutic paradigm from symptom management to fundamental cures for conditions including Alzheimer's and Parkinson's diseases. BIORCHESTRA specializes in RNAi, mRNA, and novel drug delivery systems targeting central nervous system (CNS) diseases, with active programs in early diagnostics and clinical development. The company has offices at One Kendall Square in Cambridge, Massachusetts, and at its founding location in Daejeon, South Korea, and actively seeks global R&D and commercialization partners. Founded in 2016 by Dr. Branden Ryu, BIORCHESTRA has participated in high-level state diplomatic engagements, reflecting the strategic importance of its pipeline.

Summary

It lists 51–200 employees.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biorchestra on Indexed.vc
<a href="https://indexed.vc/companies/biorchestra"><img src="https://indexed.vc/api/badge/company/biorchestra" alt="Biorchestra on Indexed.vc" width="260" height="76" /></a>